RxDoctor Payments DataLook up a doctor →

Scott Towbin, MD

Adult Medicine · Port St Lucie, FLNPI 1750319521

Payments from drug & device makers

$7,311in general payments, 2019–2025

Across 381 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$846
  • Novo Nordisk$840
  • AstraZeneca$555
  • Lilly USA, LLC$541
  • Pfizer$533
  • Amgen$418
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$6,89394%
  • Education$631%
  • Other$3555%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,311 in reported general payments places this provider in the 85th percentile of 195 adult medicine providers in Florida.

See all adult medicine providers in Florida

Medicare billing

Part B allowed, 2024
$168,933
Medicare patients
640
Services billed
3,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide262$355,262
EliquisApixaban173$233,105
MounjaroTirzepatide142$160,407
Trelegy ElliptaFluticasone/Umeclidin/Vilanter88$92,089
JardianceEmpagliflozin63$88,379
XareltoRivaroxaban67$87,227
WegovySemaglutide57$75,970
LinzessLinaclotide41$49,302
RybelsusSemaglutide24$32,993
JanuviaSitagliptin Phosphate20$31,905
FarxigaDapagliflozin Propanediol25$30,165
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$28,793
MyrbetriqMirabegron29$18,782
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen357$18,282
RestasisCyclosporine12$13,998

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy, Rybelsus$840$464,225343 claims
PfizerEliquis$533$233,105173 claims
Lilly USA, LLCMounjaro$541$160,407142 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$373$110,332127 claims
Boehringer IngelheimJardiance, Combivent Respimat$244$99,81379 claims
Johnson & JohnsonXarelto$141$87,22767 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$555$70,52295 claims
AbbVieLinzess, Restasis$846$63,30053 claims
MerckJanuvia, Janumet Xr$163$45,41835 claims
Astellas Pharma US IncMyrbetriq$123$18,78229 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$6,699706 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 195 adult medicine providers in Florida.

Other adult medicine in Port St Lucie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →